News | August 25, 2025
Briefs: Mankind Pharma, Mangalam Drugs and Organics, Veerhealth Care and Shelter Pharma
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Shelter Pharma Limited is set to capitalize on the growing demand for natural health products in India
Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
Subscribe To Our Newsletter & Stay Updated
